New legislation on the good manufacturing practice (GMP) of
pharmaceutical excipients in Europe, which could complicate the
quality control of imports of excipients to the EU and make it
unattractive for some vendors to remain in...
Elsevier have launched a drug tracking and analysis tool that is
set to greatly benefit laboratory researchers working in the
pharmaceutical and biotech professionals by bringing together drug
characteristics and status within a database.
Dutch biotechnology firm Crucell has announced it will sell vaccine
manufacturer Rhein Biotech to US company Dynavax for around $12m
(€10m) as it chooses to focus on specialised vaccines such as those
for Ebola and malaria.
Inspection technology specialist PTI has launched a new
non-invasive inspection system at INTERPHEX for multi-cavity
blister packaging made with any material, flat or glossy finish,
printed or nonprinted surface, allowing fast changeover...
The Optima Group's presence at this year's Interphex show in New
York was significant as it gave In-PharmaTechnologist.com the first
look at the Group's recently implemented shift in focus, resulting
in a product range...
inVentiv Health (Formerly Ventiv Health) saw its fourth quarter
profits dive in 2005 by 37 per cent after being hit by higher
interest expenses and an income tax provision, however, the company
managed to increase its sales for the...
Outsourcing-Pharma focus on: cutting the cost of clinical trials
As pharma companies flock towards Eastern Europe and India in a bid
to cut direct clinical trial costs, does outsourcing actually
translate into real world cost-savings?
Affymetrix introduces its new ChIP-On-Chip array product line that
its designers hope will provide drug researchers with new
whole-genome tools to assist scientists discover DNA-Protein
interactions.
New diabetes trials scheduled to start this spring have been
heralded as groundbreaking as researchers aim to reverse juvenile
diabetes of which numbers have been steadily on the rise in
developed nations.
Scientists have made available a powerful new tool for studying
brain development, which will help scientists discover the genetic
origins of brain cancers, which could speed development of novel
drugs to treat them.
Outsourcing company, Covalent Group, has announced the signing of a
$2.1M (€1.7M) contract to provide a range of services to support
the research and development of new therapies to treat
hyponatremia.
Researchers have discovered a series of enzyme inhibitors that
appear to block the replication of the SARS virus - a finding that
could help speed up the research and development of drugs used to
treat the killer virus.
Ranbaxy has announced the purchase of Senetek's Autoinjector rights
and assets for its proprietary disposable autoinjector for
self-administration of parenteral drugs, adding to Ranbaxy's
growing presence in the growing...
Rapid growth in the biopharmaceutical sector in China, India and
Southeast Asia has prompted US filtration specialist Pall to devote
more resources and industry experts to these regions, as the 14 per
cent growth seen in its BioPharm...
Systech and Domino Printing Sciences has announced an agreement
that will combine Systech's TIPS Serialised Product Tracking
methods with Domino's marking and coding technology as a solution
to combat counterfeit product...
Looking to establish itself in Eastern Europe, French drug maker
Sanofi-Aventis has bought a 24.9 per cent stake in Czech generic
drug firm Zentiva for $514.7m (€430m).
A simple laboratory method to treat Parkinson's disease, which
involves electric currents, has been developed by researchers, who
believe the use of this method will reduce or eliminate the need to
treat this disorder with drug...
Despite hurdles such as manufacturing overcapacity, limited drug
approvals and intense competition from Asian companies, a new
report from market research analysts Frost & Sullivan predicts
revenues in the North American fine...
Organon, Akzo Nobel's healthcare division, has conceded it will
have to close its Diosynth manufacturing plant in Scotland by the
end of the year since it cannot divest it, as the unit's lack of
competitiveness in the production...
LGC Promochem has launched its 2006 edition of its free
pharmaceutical reference substances and impurities catalogue,
providing researchers and analysts in the pharmaceutical R&D
and manufacturing generic industry with a central...
The new Automated Emitted Dose (AED) system from Astech allows for
in-line emitted dose testing of inhalers, saving time and money by
generating results from the production line which determine whether
full batch production should...
Laureate Pharma, a full service biopharmaceutical development and
protein production company, has been given a new contract by
Bradmer Pharmaceuticals to develop and manufacture its novel brain
cancer treatment for Phase III clinical...
Kendle, who has been expanding its reach across the globe,
targeting the emerging Asia Pacific and Latin American markets, has
announced the acquisition of Latin American-based contract research
organisation, International Clinical...
Responding to surging demand for its flu drug Tamiflu, Roche has
announced it is expanding its external contractors to fifteen in
nine different countries, as its needs for intermediates and
finished product increase.
According to a new report, the pharmaceutical market grew seven per
cent, to $602 billion (€501 billion) in 2005. The report
highlighted the emerging markets including China, Korea, Mexico,
Russia and Turkey, which experienced double-digit...
Outsourcing-Pharma Focus: Cutting the cost of clinical trials
Patient recruitment consumes more time than any other clinical
trial activity, costing the industry millions of dollars. However,
recruiting patients on the Internet can slash recruitment times and
bring drugs to market faster.
BioTrove and Blue Sky Biotech announce a collaborative effort to
provide a unique service solution, utilising mass
spectrometry-based high-throughput screening assays on previously
unscreenable drug targets.
A new discovery paves the way for new laboratory cancer research
after scientists have been able to explain just how a gene variant
carried in 15 per cent of the population may increase the risk of
developing cancer.
The European Union has approved new alternatives to animal testing
of drugs and chemicals, which will not only reduce the number of
animals needed for testing, but will also increase the accuracy of
the tests, thereby making the products...
Vertex Pharmaceuticals Incorporated and Cystic Fibrosis Foundation
Therapeutics, (CFFT) have announced they have entered into a
collaboration to develop a novel, oral drug candidate for the
treatment of cystic fibrosis (CF).
An innovative technology derived from plants, which is designed for
the production of new pharmaceuticals is to form the basis of a new
company that is to focus on (bio)pharma firms involved in the
discovery, development, production,...
Analytical instrumentation supplier Malvern has introduced a new
inhalation cell for its Spraytec system for particle size analysis
of aerosols and sprays, allowing the rapid characterisation of
systems such as dry powder inhalers...
Unlike with active pharmaceutical ingredients (APIs), there are no
clear governmental good manufacturing practice (GMP) guidelines for
excipients in the US, Europe or China. Now the International
Pharmaceutical Excipients Council...
British gene therapy firm Oxford Biomedica has licensed its VSV-G
viral envelope technology for gene delivery to American biotech
company VIRxSYS which hopes it can use it to successfully produce
its promising anti-HIV/AIDS product...
The European Association of Pharmaceutical Full-line Wholesalers
(GIRP) has outlined measures it is taking to keep counterfeit
medicines out of the legitimate supply chain while urging
pharmaceutical manufacturers and pharmacists...
The US Congress has asked the country's National Institute of
Environmental Health Sciences (NIEHS) to conduct research on the
connection between vaccines containing mercury and neurological
disorders, further battering public...
The Pharmaceutical Institute, provider of specialised knowledge for
the pharma industry, is now providing custom research services to
cater for those with complex research needs.
Shimadzu have introduced its latest emission spectrometer, which
has been designed for use in pharmaceutical research and
development whilst reducing reduced running-costs and high
sensitivity and low contamination.
Ventiv Health has spent the last month buying up companies. After
buying Aheris in February, the company has since agreed to acquire
US clinical services provider Synergos, as well as Canadian
healthcare marketing and communications...
The drug trial catastrophe, which has endangered the lives of six
male volunteers of which two are still in a coma, could've been
avoided after a similar study conducted last year yielded similar
side effects.
Researchers have constructed a model of an axon, which they have
used to reproduce a change in the axon's shape that is
characteristic of neurodegenerative disorders. The model provides a
new road to discovering new kinds of...
Drug discovery outfit, Tripos, has announced details of a
collaboration with Abbott, which is to concentrate on chemical
design and synthesis in a deal that mirrors, those announced
earlier in Q1 with Genzyme, GSK Research and Development...
NicOx and Merck have signed an agreement to collaborate on the
development of new antihypertensive drugs. The agreement follows
the successful completion of the companies' research collaboration,
which has generated promising...
Sigpack Systems have announced a range of pharmaceutical
applications that include integrated solutions for secondary
blister packaging and a system for packaging pharmaceutical powders
that make their debut at Achema 2006.
Millipore are to showcase a range of filtration, chromatography,
process monitoring and water purification solutions that are a part
of Millipore's response to an increase in lab investments from
pharma companies, and the emergence...
As a fever of consolidation continues to sweep the generics market,
Iceland's Actavis Group has offered to buy out Croatian rival Pliva
in a proposal which values it at $1.6bn (€1.31bn) and aims to
create the world's third...
A consortium of British private companies and a university facility
has been awarded $2.6m (€2.13m) by the UK's Department of Trade and
Industry (DTI) to produce a slow release vaccine which will
eliminate the need for booster...
Analytical technology specialists Waters Corporation and Bruker
BioSciences have entered into a collaboration agreement to provide
greater integration and connectivity between their products,
looking to increase efficiency in pharmaceutical...
Princeton Instruments/Acton has unveiled its new sensor technology
that it claims will revolutionise the world of spectroscopy and
triple the speed of current devices.
Robin Engineering Services has made its first foray into selling
machinery exclusively for the pharma industry in a deal with Indian
manufacturer Chamunda. The partnership will slash the cost of
tableting machinery and fluidised bed...
